Quercetin inhibits the expression and function of the androgen receptor in LNCaP prostate cancer cells

N Xing1, Y Chen, S H Mitchell

  • 1Department of Urology and Biochemistry and Molecular Biology, Mayo Graduate School, Mayo Foundation, Rochester, MN 55905, USA.

Carcinogenesis
|March 10, 2001
PubMed

Insights

Quercetin, a natural flavonoid, inhibits prostate cancer growth by reducing androgen receptor (AR) expression and function. This suggests quercetin

Area of Science:

  • Oncology
  • Molecular Biology
  • Natural Products Chemistry

Background:

  • Androgen receptor (AR) signaling is crucial for prostate cancer development and progression.
  • Novel therapeutic strategies targeting AR are needed to combat prostate cancer.

Purpose of the Study:

  • To investigate the effect of quercetin, a natural flavonoid, on androgen action in prostate cancer.
  • To determine if quercetin can attenuate androgen receptor (AR) function and expression.

Main Methods:

  • Western blot analysis to assess AR protein levels.
  • Measurement of prostate-specific antigen (PSA) and hK2 secretion.
  • Quantitative real-time PCR to analyze mRNA levels of androgen-regulated genes.
  • Transient transfection assays to evaluate transcriptional activity.

Main Results:

  • Quercetin significantly inhibited AR protein expression in a dose-dependent manner.
  • Quercetin reduced the secretion of androgen-regulated tumor markers PSA and hK2.
  • Quercetin down-regulated mRNA levels of AR-regulated genes, including PSA, NKX3.1, and ODC.
  • Quercetin repressed AR-mediated PSA expression and AR gene transcription.

Conclusions:

  • Quercetin attenuates androgen receptor (AR) function by repressing its expression at both protein and transcriptional levels.
  • Quercetin demonstrates potential as a chemopreventive and/or chemotherapeutic agent for prostate cancer.